In this issue:
- Amivantamab in EGFR Exon 20 insertion NSCLC
- Tumour Treating Fields therapy
- Perioperative immunotherapy for NSCLC:
- Pembrolizumab
- Nivolumab
- Durvalumab
- Multigene panel next-generation sequencing
- Air pollution and lung cancer
- Radiology facilities and promotion of smoking cessation
- Low-dose CT screening for lung cancer
- Global variations in lung cancer incidence
Please login below to download this issue (PDF)